IP Library Granted Patent US 8,731,630
Granted Patent B2
US 8,731,630 · App. 12/729,058 · Granted May 20, 2014

Transcutaneous analyte sensor

Inventors: Apurv Ullas Kamath (San Diego, CA); James Brauker (Addison, MI); J. Michael Dobbles (San Diego, CA)
Assignee: DexCom, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,731,630
App. No.
12/729,058
Granted
May 20, 2014
Kind
B2
Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims (25)

1. An analyte monitoring system, the system comprising:

an analyte sensor;

a processor coupled to the sensor and configured to provide sensor data indicative of a concentration of glucose measured by the analyte sensor in a subcutaneous tissue of a host; and

a user interface configured to provide real-time glucose information based on calibrated sensor data to a user, wherein the system is configured to calibrate the analyte sensor using reference data from a reference analyte monitor, wherein the calibration is allowed when an absolute rate of change of a calculated glucose concentration is less than about 4 mg/dL/min, and wherein the calibration is suspended when the absolute rate of change of the calculated glucose concentration is greater than about 4 mg/dL/min.

2. The system of claim 1 , wherein the system is configured to prospectively calibrate the analyte sensor.

3. The system of claim 1 , wherein the system is configured to calculate the rate of change of the glucose concentration from calibrated sensor data.

4. The system of claim 1 , wherein the analyte sensor is a subcutaneous glucose sensor configured to continuously measure a glucose concentration in a subcutaneous tissue of a host.

5. The system of claim 1 , wherein the analyte sensor is a transcutaneous glucose sensor configured to continuously measure a glucose concentration in a subcutaneous tissue of a host.

6. The system of claim 1 , wherein the sensor data is indicative of the continuous concentration of glucose in the subcutaneous tissue of the host over a period of time.

7. The system of claim 1 , wherein the reference analyte monitor is a self-monitoring blood glucose meter.

8. The system of claim 1 , wherein the reference data is indicative of a blood glucose concentration withdrawn from a finger stick and analyzed by the reference analyte monitor.

9. The system of claim 1 , wherein the system is configured to calibrate the analyte sensor multiple times over a period of time.

10. A method of calibrating an analyte monitoring system, the method comprising:

receiving sensor data from an analyte sensor, wherein the sensor data is indicative of a glucose concentration measured in a subcutaneous tissue of a host;

receiving reference data from a reference analyte monitor;

calibrating, using an electronic system, the analyte sensor using the reference data, wherein calibrating comprises allowing calibration when an absolute rate of change of a calculated glucose concentration is less than about 4 mg/dL/min and suspending calibration when the absolute rate of change of the calculated concentration is greater than about 4 mg/dL/min; and

providing real-time glucose information based on calibrated sensor data.

11. The method of claim 10 , wherein the calibrating is performed prospectively.

12. The method of claim 10 , further comprising calculating the rate of change of the glucose concentration from calibrated sensor data.

13. The method of claim 10 , wherein the analyte sensor is a subcutaneous glucose sensor configured to continuously measure a glucose concentration in a subcutaneous tissue of a host.

14. The method of claim 10 , wherein the analyte sensor is a transcutaneous glucose sensor configured to continuously measure a glucose concentration in a subcutaneous tissue of a host.

15. The method of claim 10 , wherein the sensor data is indicative of the continuous concentration of glucose in the subcutaneous tissue of the host over a period of time.

16. The method of claim 10 , wherein the reference analyte monitor is a self-monitoring blood glucose meter.

17. The method of claim 10 , wherein the reference data is indicative of a blood glucose concentration withdrawn from a finger stick and analyzed by the reference analyte monitor.

18. The method of claim 10 , further comprising performing a first calibration of the analyte sensor prior to performing the calibration of the analyte sensor using the reference data.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2010
From: KAMATH, APURV ULLAS; BRAUKER, JAMES; DOBBLES, J. MICHAEL
To: DEXCOM, INC.
Reel/Frame 024181/0661 →
Continuity (6)
Continuation 11077739 · Mar 10, 2005
Provisional Application 60587787 · Jul 13, 2004
Provisional Application 60587800 · Jul 13, 2004
Provisional Application 60614683 · Sep 30, 2004
Provisional Application 60614764 · Sep 30, 2004
Related Publication 20100174158A1 · Jul 8, 2010